LIGAND PHARMACEUTICALS INC — Director's Dealing 2020

Dec 10, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LIGAND PHARMACEUTICALS INC (LGND)
CIK: 0000886163
Period of Report: 2020-12-08

Reporting Person: HIGGINS JOHN L (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-08	Common Stock	M	14657	$10.05	Acquired	236770	Direct
2020-12-08	Common Stock	F	1683	$87.52	Disposed	235087	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-08	Non-Qualified Stock Option (right to buy)	$10.05	M	14657	Disposed	2021-02-17	Common Stock (14657)	Direct

Footnotes

F1: Represents previously-owned shares delivered to the Issuer in payment of the exercise price of the stock options.

F2: Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 02/17/11.